Skip to main content
Premium Trial:

Request an Annual Quote

Plan S for Open Access

Plan S requirements go into effect this month, Science writes, noting there are many ways scientists can fulfill its open-access mandates.

The Plan S initiative, developed by Science Europe, a coalition of European funding agencies, launched in 2018 to push for scientific research to be freely available upon publication. The initiative has garnered the support of additional countries as well as of research-funding charities like the Bill & Melinda Gates Foundation and the Wellcome Trust.

As Science notes, there are a number of ways researchers can meet the initiative's open-access requirements, such as paying a fee to make an article open-access or depositing an article into an open-access repository. But those fees can be high, it adds. Springer Nature recently announced that its fees for open-access publishing in the Nature family of journals would run €9,500 (US $11,390), though it is examining lower fees of €4,790 for a few journals including Nature Genetics.

Science adds that Plan S has also spurred new agreements between research institutions and publishers, such as between Project Deal, a group of German libraries and research institutes, and publishers like Wiley and Springer Nature. 

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.